2012
DOI: 10.1161/hypertensionaha.112.201459
|View full text |Cite
|
Sign up to set email alerts
|

Differential Diagnosis of Preeclampsia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
12
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(14 citation statements)
references
References 43 publications
2
12
0
Order By: Relevance
“…It also minimizes the risk of including patients with preexisting disease such as systemic lupus erythematosus. 13 However, it should be noted here that a reanalysis on the basis of a subdivision according clinical diagnosis yielded identical results (data not shown).…”
Section: Discussionsupporting
confidence: 57%
See 1 more Smart Citation
“…It also minimizes the risk of including patients with preexisting disease such as systemic lupus erythematosus. 13 However, it should be noted here that a reanalysis on the basis of a subdivision according clinical diagnosis yielded identical results (data not shown).…”
Section: Discussionsupporting
confidence: 57%
“…It also minimizes the risk of including patients with preexisting disease such as systemic lupus erythematosus. 13 However, it should be noted here that a reanalysis on the basis of a subdivision according clinical diagnosis yielded identical results (data not shown).A high antiangiogenic state, as reflected by elevated sFlt-1 levels, is associated with increased ET-1 levels. Given the observation that ET-1 also rises in patients with cancer and rats treated with the VEGF inhibitor sunitinib ( Figure 1A), 6 the most logical explanation of this ET-1 rise is that it is the direct consequence of VEGF inhibition, either through VEGF inactivation by sFlt-1 (in preeclampsia) or through interference with VEGF signaling (with sunitinib).…”
supporting
confidence: 58%
“…The soluble fms-like tyrosine kinase 1/placental growth factor ratio defined by Verdonk et al may also help identify a disease flare-up. 23) Pregnancy in SLE patients is considered high risk, and management should start before conception. Pregnancy should be planned when patient health is optimal, i.e., when the disease is in clinical remission for at least 6 months, and while on a decreased steroid dosage.…”
Section: Discussionmentioning
confidence: 99%
“…[67][68][69][70][71] Angiogenic markers have also been shown to be promising in preeclampsia-related disorders, such as idiopathic fetal growth restriction and stillbirth. 72,73 To demonstrate clinical use of these biomarkers, we led a large clinical study to evaluate the role of angiogenic biomarkers in the prediction of preeclampsia-related adverse outcomes among women evaluated at our institution for suspected preeclampsia.…”
Section: Biomarker Studies In Preeclampsiamentioning
confidence: 99%